Search results - 490 results

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Publication Type: Peer reviewed scientific article Authors: Adriaenssens, Niels; Scholtes, Beatrice; Bruyndonckx, Robin; Jan Y Verbakel; De Sutter, An; Heytens, Stefan; Van Den Bruel, Ann; Desombere, Isabelle; Van Damme, Pierre; Goossens, Herman; Buret, L ...

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Publication Type: Peer reviewed scientific article Authors: Adriaenssens, Niels; Scholtes, Beatrice; Bruyndonckx, Robin; Van Ngoc, Pauline; Verbakel, Jan Yvan Jos; De Sutter, An; Heytens, Stefan; Van Den Bruel, Ann; Desombere, Isabelle; Van Damme, Pierre; ...

Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort studyObjectivesDesignSettingParticipantsOutcome measuresResultsConclusionsTrial registration number

Publication Type: Peer reviewed scientific article Authors: Mortgat, Laure; Verdonck, Kristien; Veronik Hutse; Isabelle Thomas; Barbezange, Cyril; Heyndrickx, Leo; Fischer, Natalie; Vuylsteke, Bea; Kabouche, Ines; Ariën, Kevin K; Desombere, Isabelle; Duys ...

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

that a fractional dose induces comparable antibody responses to the full dose in people <55 years. Here, we report the safety and immunogenicity of a fractional dose regimen of the BNT162 b2 vaccine. ...

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

NHR, are known to have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 ...

Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.

assessed by SARS-CoV-2 anti- S1 IgG antibody levels and SARSC oV-2 50% neutralization titers (NT50) against Wuhan and BA.1 Omicron strains. Cellular immunity was examined by analyzing CD4 + and CD8 + T cell ...

Tick-Borne Encephalitis Virus Prevalence in Sheep, Wild Boar and Ticks in Belgium.

Keywords: Animals Antibodies, Viral Belgium Encephalitis Viruses, Tick-Borne Encephalitis, Tick-Borne prevalence Seroepidemiologic Studies Sheep Sus scrofa Swine Ticks Abstract: Tick-borne encephalitis virus ...

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.

prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers (PHCP s). DESIGN: Prospective cohort study with 12 months of follow-up. SETTING: Primary care in Belgium. ...

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.

assigned in a 2:1 ratio to receive either camostat mesylate or a placebo. Outcomes included change in nasopharyngeal viral load, time to clinical improvement, the presence of neutralizing antibodies ...

QR code

QR code for this page URL